Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the... see more

TSX:CPH - Post Discussion

Cipher Pharmaceuticals Inc > Healthcare picks: After CPH, I pick Viemed (VMD)
View:
Post by stockfy on Jun 10, 2021 5:20am

Healthcare picks: After CPH, I pick Viemed (VMD)

Unlike many investors including the clueless analyst from Stifel Justin Keywood, I was very bullish on CPH at C$0.80 and C$0.90 just a few months ago and I also posted facts on this board why I was bullish on CPH at those price levels. These facts and reasons were from CPH's press releases and reports. Zero speculation. CPH is at C$1.55 now.

My new pick from the healthcare sector is Viemed Healthcare (VMD) now at C$9.

VMD has a pristine balance sheet and is dirt cheap now at C$9 trading just 7 times its 2021 adj. EBITDA and 1.5 times its 2021 revenue.

VMD also has many catalysts ahead including many growth initiatives, both organic and inorganic. These are facts. Read the latest Conference Call to see these facts and growth initiatives. The CC is posted on Seeking Alpha.
Comment by stockfy on Jun 19, 2021 1:06pm
Does Justin Keywood still have a job in Stifel? 
Comment by stockfy on Aug 29, 2021 11:02am
With CPH at C$2.23,  does Justin Keywood still have a job in Stifel?   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities